Pricing Log in Create free account

Artiva Biotherapeutics, Inc. (ARTV) vs Surrozen, Inc. (SRZN)

Artiva Biotherapeutics, Inc. and Surrozen, Inc. are both Biotechnology companies. Artiva Biotherapeutics, Inc. and Surrozen, Inc. are of similar size ($296.3M and $294.7M). Artiva Biotherapeutics, Inc. has the higher net margin (0.00% vs −2,887.1%) and the higher return on invested capital (0.00% vs 0.00%). Across the 10 metrics below, Artiva Biotherapeutics, Inc. leads on 8 and Surrozen, Inc. on 2.

Valuation

Metric ARTV SRZN Biotechnology median
P/E n/m n/m 8.50
P/S n/m 23.78 9.71
P/B 0.66 n/m 2.13
Price to free cash flow n/m n/m 20.82
EV/EBITDA 1.27 n/m 0.64
EV/Sales n/m 14.92 9.21
Earnings yield (56.41%) (159.31%) (33.15%)
Free cash flow yield (33.36%) (12.78%) (25.50%)

Profitability

Metric ARTV SRZN Biotechnology median
Gross margin — 100.00% 65.16%
Operating margin 0.00% (385.28%) 0.00%
Net margin 0.00% (2,887.07%) 0.00%
Free cash flow margin 0.00% (303.92%) 0.00%
Return on equity (36.58%) 387.44% (56.36%)
Return on assets (33.76%) (304.47%) (48.04%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric ARTV SRZN Biotechnology median
Revenue growth (TTM) — (8.79%) 6.02%
EPS growth (last fiscal year) 40.96% (49.38%) 30.26%
Revenue growth, 5-year CAGR — — 9.41%
Net income growth, 5-year CAGR — 0.00% 0.00%

Health

Metric ARTV SRZN Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 24.16 12.14 4.72
Net debt to EBITDA 1.24 2.15 0.96

Dividend

Metric ARTV SRZN Biotechnology median
Dividend yield — — 0.09%
Payout ratio — — —

Size

Metric ARTV SRZN Biotechnology median
Market cap 296.27m 294.66m 135.18m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack